Oil Technologies Ltd News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Heil s Experience Commerce wins digital mandate for SAVSOL engine oil
adgully.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from adgully.com Daily Mail and Mail on Sunday newspapers.
Savita Oil Technologies Ltd posts QoQ fall in PAT to Rs 56 08 crore in Q2FY22
equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.
Savita Oil Technologies Ltd reports Q1FY22 net profit of Rs 77 53 crores
equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.
Savita Oil Technologies Ltd posts rise in PAT to Rs 94 53 crores in Q4 FY2020-21
equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Pharmagreen Extends the Letter of Intent Timeline with Advanced Bio-Oil Technologies Ltd.
Pharmagreen Biotech Inc.April 19, 2021 GMT
CARSON CITY, NV, April 19, 2021 (GLOBE NEWSWIRE) via NewMediaWire Pharmagreen Biotech, Inc., (OTC PINKS: PHBI), announces that the signed letter of intent with Advanced Bio-oil Technologies Ltd. (ABOT), based in Denver, Colorado, as announced on February 16, 2021 has been extended by mutual agreement between the parties to June 30, 2021.
Pharmagreen to date has identified a number of opportunities for acquisition and further development of the assets for tissue culture starter plantlet production, extraction and product formulation. As stated in February 16, 2021 news release, Pharmagreen will provide the raw, crude Cannabiniod oils, grown by its network of local hemp farmers and the Cannabiniod product formulations will be developed as a joint ventu